Silymarin: An option to treat non-alcoholic fatty liver disease.

Silymarin: An option to treat non-alcoholic fatty liver disease. World J Gastroenterol. 2017 Dec 21;23(47):8437-8438 Authors: Colica C, Boccuto L, Abenavoli L Abstract We have read with a great interest the review published by Singh et al, on the treatment options in alcoholic and non-alcoholic fatty liver disease, including various new targeted therapies that are currently under investigation. Recently, we described the health effects of the Mediterranean diet associated to an antioxidant complex rich in silymarin, to improve in overweight patients anthropometric parameters, glucose and lipid metabolism and intra-hepatic fat accumulation. PMID: 29309065 [PubMed - indexed for MEDLINE]
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Tags: World J Gastroenterol Source Type: research